Corporate & Securities

Mergers & Acquisitions

Mergers and acquisitions can be fraught with complications, especially in an increasingly complex business and regulatory environment. We know that a successful outcome requires a delicate balance among the legal, business, and operational interests of a company.

We employ a team approach to your merger or acquisition to provide practiced and practical advice throughout every step of the transaction — from the initial structuring and negotiation to implementation and even post-closing. We can call upon the diverse backgrounds of lawyers in our Corporate & Securities; Antitrust; Employment, Labor & Benefits; Environmental Law; Intellectual Property; Real Estate; Tax; and other practices to help you complete a successful transaction.

Our substantial experience in industries from life sciences and technology to health care  and telecommunications enables us to assist you in navigating the myriad of regulatory issues that may arise.

Quick Facts

  • More than 100 mergers and acquisitions since 2012, with an aggregate deal value of close to $11 billion
  • Interdisciplinary team handles key issues from due diligence through closing
  • Focus on the middle market
  • Focus on emerging and regulated industries:
  • Represent entrepreneurs, publicly traded companies, financial advisors, private equity and venture capital funds, independent committees, executives, and lenders
  • Diverse portfolio of completed transactions
  • Recommended by The Legal 500 United States for Mergers, Acquisitions and Buyouts - M&A: Middle-Market (sub-$500m) (2013)

Areas of Focus

  • Asset sales
  • Cash tender offers
  • Cross-border and international transactions
  • Exchange offers
  • Going private transactions
  • Hostile transactions
  • Leveraged buyouts
  • Management buyouts
  • Mergers
  • Proxy contests
  • Recapitalizations
  • Roll-ups
  • Spin-outs
  • Stock sales

Sort by: Name  Title  Office

Priya K. Agrawal

Priya K. Agrawal


New York (212) 692-6708
Boston 617-348-3084
Avisheh Avini

Avisheh Avini

Of Counsel

New York (212) 692-6200
Brady Berg

Brady Berg


San Francisco (415) 432-6003
New York (212) 692-6869
Boston (617) 348-4498
New York (212) 692-6784
Boston (617) 348-1840
Boston (617) 348-1742
Hannah C. Coman

Hannah C. Coman


Boston (617) 348-1703
Boston (617) 348-4716
Boston (617) 348-1797
Robert Duggan

Robert Duggan


Boston (617) 348-1780
New York (212) 692-6730
Boston (617) 348-1635
Boston (617) 348-1640
Boston (617) 348-3003
Boston (617) 348-4474
Boston 617-348-1735
Boston (617) 348-4443
Boston (617) 348-1834
Kristin A. Gerber

Kristin A. Gerber


Boston 617-348-3043
Merav Gershtenman

Merav Gershtenman


New York (212) 692-6806
San Diego (858) 314-1515
San Francisco (415) 432-6000
Dennis I. Greene

Dennis I. Greene

Member Emeritus

Boston (617) 348-1649
Boston (617) 348-1654
Kanasha S. Herbert

Kanasha S. Herbert


Boston 617-348-3015
Boston (617) 348-1799
New York (212) 692-6830
Boston (617) 348-1706
Boston (617) 348-1715
Boston (617) 239-8491
New York 212-692-6882
Boston 617-348-1669
New York (212) 692-6768
Boston (617) 348-1674
New York 212-692-6884
Boston (617) 348-1732
Boston (617) 348-3032
San Diego (858) 314-1509
San Francisco (415) 432-6104
Washington, DC (202) 434-7452
San Diego (858) 314-1519
Lauren J. Luptak

Lauren J. Luptak


New York 212-692-6299
Boston 617-348-3058
New York (212) 692-6794
Boston (617) 348-1691
Boston (617) 348-1696
New York 212-692-6785
Linda Rockett

Linda Rockett


Boston (617) 348-4888
San Diego (858) 314-1527
Los Angeles (310) 586-3200
San Francisco (415) 432-6080
Joseph J. Ronca

Joseph J. Ronca


New York 212-692-6298
John T. Rudy

John T. Rudy


Boston (617) 348-3050
San Diego (858) 314-1873
Boston (617) 348-1798
New York (212) 692-6732
Bram Shapiro

Bram Shapiro


Boston (617) 348-1610
Boston 617-348-1619
Boston (617) 348-1749
Boston (617) 210-6854
Boston (617) 348-1869
Boston (617) 348-1759
Garrett M. Winslow

Garrett M. Winslow


Boston (617) 348-3028
Ran Zioni

Ran Zioni

International Member

Washington, DC (202) 434-7456
Dean G. Zioze

Dean G. Zioze


Boston (617) 348-4795

Representative Experience

  • Represented Time Inc. in its spin-off from Time Warner, creating an independent NYSE-listed public company.
  • Represented Chyron Corporation (NASDAQ:CHYR), a New York-based worldwide leader in broadcast graphics in real time, in its $35M acquisition of Hego Group, a Swedish based company focused on tracking sports data.
  • Represented Boston Biomedical, Inc. (BBI) in its sale to Dainippon Sumitomo Pharma Co., Ltd. (DSP) for up to $2.63 billion in total, which included $200 million upfront, up to $540 million in development milestone payments, and up to $1.89 billion in sales milestone payments.
  • Represented American Technical Ceramics Corporation in its $231 million sale to AVX Corporation.
  • Represented Caliper Life Sciences, Inc. in its $600 million sale to Perkin Elmer, Inc.
  • Represented AIM listed special purpose acquisition company (SPAC) International Consolidated Minerals, Inc., formerly Platinum Diversified Mining, Inc., in its $250 million acquisition of International Consolidated Minerals Limited.
  • Represented Alloy, Inc. in the $36 million sale of its FrontLine in-store marketing division to Acosta Sales & Marketing.
  • Represented AMICAS, Inc. in its $215 million sale to Merge Healthcare, Incorporated.
  • Represented Ion Torrent Systems, Inc. in its $725 million sale to Life Technologies Corporation.
  • Represented Navios Maritime Acquisition Corporation in its $457.7 million acquisition of assets.
  • Represented QIAGEN NV in its $1.6 billion acquisition of Digene Corporation, including antitrust aspects of the transaction.
  • Represented the exclusive financial advisor to Diagnostic Products Corporation in its $1.8 billion acquisition by Siemens Medical Solutions.
  • Represented China-based BioDuro, LLC in its $77 million acquisition by Pharmaceutical Product Development, Inc.
  • Represented Vertex Pharmaceuticals, Inc. in its $400 million acquisition of ViroChem Pharma, Inc.
  • Served as special US counsel to Nippon Sheet Glass Co., Ltd. in its $3.5 billion acquisition of Pilkington, PLC.
  • Represented CVS in the antitrust aspects of its $2.7 billion acquisition of Longs Drugs.
  • Represented CVS in the antitrust aspects of its $27 billion acquisition of Caremark.
  • Represented the general counsel of a homeland security company being acquired in a multibillion-dollar transaction. During the due diligence phase of the acquisition, the acquiring company discovered bribes paid to officials in West Africa. This matter was resolved successfully for our client despite charges being made against additional individuals associated with the company.
  • Advised a health care and life sciences private equity firm on its acquisition of a pathology laboratory company.
  • Counseled a nationwide dialysis services provider on a variety of transactions involving both acquisitions of dialysis clinics and joint ventures with dialysis providers throughout the United States.
  • Representation of a major cable television provider in connection with a high-profile merger proceeding before the Department of Justice and state attorneys general.
  • Represented a cable company in the first successful FTC clearance of the acquisition of an overbuilt cable system.